Tochigi, Japan

Eirin Sai


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eirin Sai in Cancer Research

Introduction

Eirin Sai is an accomplished inventor based in Tochigi, Japan, whose significant contributions to the field of cancer research have been recognized with a patent. Her work focuses on elucidating novel causative genes for cancer, paving the way for advanced detection methods that could revolutionize cancer diagnostics.

Latest Patents

Eirin Sai holds a patent for a "Detection method for novel ROS1 fusions." This innovative detection method involves polynucleotides that are identified as novel causative genes for cancer. The patent outlines a technique for detecting these polynucleotides or the polypeptides encoded by them, alongside a kit and primer set designed for this purpose. The approach involves detecting a fusion gene that combines segments of specific genes, including SDC4, CD74, EZR, SLC34A2, LRIG3, or TPM3 with part of the ROS1 gene. The methods outlined in her patent include a sense primer based on the aforementioned genes and an antisense primer based on ROS1.

Career Highlights

Eirin Sai has had a notable career, working with leading organizations such as the Japanese Foundation for Cancer Research and the Educational Foundation Jichi Medical University. Her experiences in these institutions have undoubtedly enriched her knowledge and expertise in cancer research, further contributing to her innovative projects and findings.

Collaborations

During her career, Eirin has collaborated with esteemed colleagues, including Kengo Takeuchi and Yuichi Ishikawa. These partnerships have likely fostered a dynamic exchange of ideas that has propelled her research forward, leading to the successful development of her groundbreaking patent.

Conclusion

Eirin Sai's pioneering work in the detection of novel ROS1 fusions highlights her role as an innovative force in cancer research. Her patent exemplifies her commitment to advancing scientific understanding and improving diagnostic methods for cancer, paving the way for future breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…